Graphite Bio Inc. (GRPH) NASDAQ
$3.27 - (-)
Market Cap: $185.19M
As of 03/20/24 12:00 AM EDT. Market closed.
Graphite Bio Inc. (GRPH)
NASDAQ
$3.27
- (-)
Market Cap: $185.19M
As of 03/20/24 12:00 AM EDT. Market closed.
Add to Portfolio
graphite bio is a next-generation gene editing company focused on the development of first-in-class therapies for patients suffering from life-threatening genetic diseases. the company’s platform harnesses the natural cellular process of homology directed repair (hdr) and targeted dna integration to precisely repair genetic defects at their source. graphite bio is leveraging its differentiated ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
Address
.
PRICE CHART FOR GRAPHITE BIO INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$3.14
Previous Close
$3.27
Days Range
$3.05 - $3.23
52 week range
$2.01 - $4.26
Volume
494,389
Avg. Volume (30 days)
563,308
Market Cap
$185.19M
Dividend Yield
-
P/E
-
Shares Outstanding
58,236,926
Open
$3.14
Previous Close
$3.27
Days Range
$3.05 - $3.23
52 week range
$2.01 - $4.26
Volume
494,389
Avg. Volume (30 days)
563,308
Market Cap
$185.19M
Dividend Yield
-
P/E
-
Shares Outstanding
58,236,926
FINANCIAL STATEMENTS FOR GRAPHITE BIO INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR GRAPHITE BIO INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| RA CAPITAL MANAGEMENT, L.P. | Director | Mar 21, 2024 | Buy | $15.03 | 998,009 | 15,000,075 | 3,319,339 | Mar 25, 2024, 08:48 PM |
| MCCOLLUM JAMES W | Director | Mar 21, 2024 | Option Exercise | $15.03 | 16,633 | 249,992 | 494,233 | Mar 25, 2024, 08:42 PM |
| Samsara BioCapital, L.P. | 10% Owner | Apr 12, 2022 | Buy | $4.08 | 350,000 | 1,428,000 | 8,459,314 | Apr 13, 2022, 07:40 PM |
| Samsara BioCapital, L.P. | 10% Owner | Apr 11, 2022 | Buy | $4.07 | 74,464 | 303,068 | 8,109,314 | Apr 13, 2022, 07:40 PM |
| Gutry Phil | CHIEF BUSINESS OFFICER | Apr 11, 2022 | Buy | $4.01 | 5,000 | 20,050 | 299,941 | Apr 13, 2022, 07:35 PM |
| Samsara BioCapital, L.P. | 10% Owner | Jan 24, 2022 | Buy | $8.70 | 23,000 | 200,100 | 8,034,850 | Jan 25, 2022, 02:30 PM |
| Samsara BioCapital, L.P. | 10% Owner | Jan 21, 2022 | Buy | $8.99 | 100,000 | 899,000 | 8,011,850 | Jan 25, 2022, 02:30 PM |
| Samsara BioCapital, L.P. | 10% Owner | Jan 19, 2022 | Buy | $9.24 | 54,565 | 504,181 | 7,868,745 | Jan 21, 2022, 01:48 PM |
| Samsara BioCapital, L.P. | 10% Owner | Jan 20, 2022 | Buy | $8.92 | 43,105 | 384,497 | 7,911,850 | Jan 21, 2022, 01:48 PM |
| Samsara BioCapital, L.P. | 10% Owner | Dec 15, 2021 | Buy | $10.19 | 22,329 | 227,533 | 7,814,180 | Dec 20, 2021, 01:46 PM |
| Samsara BioCapital, L.P. | 10% Owner | Nov 22, 2021 | Buy | $10.15 | 201,685 | 2,047,103 | 7,791,851 | Nov 24, 2021, 01:31 PM |
| Samsara BioCapital, L.P. | 10% Owner | Oct 15, 2021 | Buy | $12.49 | 2,300 | 28,727 | 7,590,166 | Oct 15, 2021, 06:06 PM |
| Samsara BioCapital, L.P. | 10% Owner | Oct 14, 2021 | Buy | $12.50 | 3,100 | 38,750 | 7,587,866 | Oct 15, 2021, 06:06 PM |
| Samsara BioCapital, L.P. | 10% Owner | Oct 13, 2021 | Buy | $13.22 | 45,400 | 600,188 | 7,584,766 | Oct 15, 2021, 06:06 PM |
| Samsara BioCapital, L.P. | 10% Owner | Oct 08, 2021 | Buy | $13.12 | 75,000 | 984,000 | 7,539,366 | Oct 08, 2021, 05:09 PM |
| Samsara BioCapital, L.P. | 10% Owner | Oct 07, 2021 | Buy | $14.94 | 9,021 | 134,774 | 7,464,366 | Oct 08, 2021, 05:09 PM |
| Samsara BioCapital, L.P. | 10% Owner | Oct 06, 2021 | Buy | $13.83 | 61,475 | 850,199 | 7,455,345 | Oct 08, 2021, 05:09 PM |
| Versant Venture Capital VI, L.P. | 10% Owner | Jun 29, 2021 | Buy | $17.00 | 180,000 | 3,060,000 | 1,707,719 | Jul 01, 2021, 07:01 PM |
| Jerel Davis | Director | Jun 29, 2021 | Buy | $17.00 | 180,000 | 3,060,000 | 1,707,719 | Jul 01, 2021, 07:01 PM |
| Shah Smital | Director | Jun 29, 2021 | Buy | $17.00 | 5,882 | 99,994 | 5,882 | Jul 01, 2021, 07:00 PM |
| Gutry Phil | CHIEF BUSINESS OFFICER | Apr 18, 2021 | Option Exercise | $6.11 | 3,383 | 20,670 | 285,345 | Jul 01, 2021, 07:00 PM |
| Gutry Phil | CHIEF BUSINESS OFFICER | Jan 15, 2021 | Option Exercise | $0.30 | 91,406 | 27,422 | 281,962 | Jul 01, 2021, 07:00 PM |
| JIMENEZ JOSEPH | Director | Jan 14, 2021 | Option Exercise | $0.30 | 49,876 | 14,963 | 153,815 | Jul 01, 2021, 07:00 PM |
| Lehrer-Graiwer Joshua | PRESIDENT AND CEO | Jan 16, 2021 | Option Exercise | $0.30 | 374,013 | 112,204 | 1,153,544 | Jul 01, 2021, 07:00 PM |
| Samsara BioCapital, L.P. | 10% Owner | Jun 29, 2021 | Buy | $17.00 | 500,000 | 8,500,000 | 7,393,870 | Jul 01, 2021, 05:39 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Load More Insider Transactions
FUNDS WITH A POSITION IN GRAPHITE BIO INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BLACKROCK INC. | 1,760,019 | 0.00012% | -2.47% | Other |
| RENAISSANCE TECHNOLOGIES LLC | 581,156 | 0.00236% | 119.8% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 555,153 | 0.00015% | 3.27% | Other |
CHANGE IN SHARES OUTSTANDING FOR GRAPHITE BIO INC
STOCK BUYBACKS FOR GRAPHITE BIO INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
0.97%
1Q
06/30/2023
1.88%
2Q
03/31/2023
3.49%
3Q
12/31/2022
3.76%
4Q
09/30/2022
4.72%
5Q
06/30/2022
5.94%
6Q
03/31/2022
7.05%
7Q
09/30/2021
9.56%
9Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR GRAPHITE BIO INC
LOADING...